Huang Lian
Also known as: Rhizoma Coptidis
Recent Insights
Berberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance.
Huang Bai Huang Lian
Related Topics
Research Articles
Published research studies are articles that present the findings of original research that has undergone a peer-review process and has been made publicly available in scholarly journals, books or other media.
How to submit an article:
- Registered users can submit any published journal article that has a unique DOI (Digital Object Identifier) name or link to Research Hub.
- For example, you can paste the full DOI link:
https://doi.org/10.1109/5.771073
or just the DOI name:10.1109/5.771073
into the field above and click submit. - The person who is first to submit a valid article to Research Hub will forever be credited for it, and every article submission earns you +6 Research Points.
Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2021 Apr 26 Frontiers in Pharmacology Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y, et al.
Berberine can improve obesity and hyperlipidemia by reducing triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL) and increasing high-density lipoprotein (HDL); reduce insulin resistance to improve type Ⅱ diabetes; and prevent diabetic encephalopathy.
Systematic Review Meta-Analysis Huang Lian Metabolic SyndromeCoptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology
2019 Jan 01 Pharmaceutical Biology Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, et al.
As an important herbal medicine in Chinese medicine, CR has the potential to treat various diseases. However, further research should be undertaken to investigate the clinical effects, toxic constituents, target organs and pharmacokinetics, and to establish criteria for quality control, for CR and its related medications. In addition, the active constituents, other than alkaloids, in both raw and processed products of CR should be investigated.
Review Article Huang LianThe Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review
2018 Nov 14 Evidence-Based Complementary and Alternative Medicine Meng-Fei Li, Xiao-Meng Zhou, Xue-Lian Li
Systematic Review Meta-Analysis Huang Bai Huang LianBerberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance.
System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus
2017 Oct 05 Frontiers in Pharmacology Yue S-J, Liu J, Feng W-W, Zhang F-L, Chen J-X, Xin L-T, et al.
These results successfully explained the polypharmcological and synergistic mechanisms underlying the efficiency of Huangqi and Huanglian for the treatment of DM and its complications.
Network Pharmacology Type 2 Diabetes Huang LianRhizoma Coptidis: A Potential Cardiovascular Protective Agent
2016 Oct 07 Frontiers in Pharmacology Tan HL, Chan KG, Pusparajah P, Duangjai A, Saokaew S, Mehmood Khan T, et al.
In conclusion, results of recent studies appear to support for the usage of RC for treatment of CVDs and related conditions. RC appears to have tremendous potential as a cardioprotective agent given its ability to improve a large number of parameters associated with increased risk of CVDs including anti-atherosclerotic effect, lipid-lowering effect, anti-obesity effect and anti-hepatic steatosis effect. Aside from reducing incidence, it also reduces the damage caused by CVDs as it confers protection from myocardial I/R injury. However, knowledge regarding the underlying mechanisms of action of these compounds is still limited. More research investigating the exact mechanisms of RC's cardioprotective activities is needed.
Review Article Huang Lian Cardiovascular DiseaseResearch Insights
Insights are moderated by the Research Hub team and offer an at-a-glance overview of interesting research findings.
Berberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance.
2018 Evidence-Based Complementary and Alternative Medicine The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review Meng-Fei Li, Xiao-Meng Zhou, Xue-Lian Li
Systematic Review Huang Bai
The passage outlines the outcomes of a comprehensive study conducted in the context of treating polycystic ovary syndrome with insulin resistance (PCOS-IR). The study involved screening 225 potential studies, ultimately selecting 9 trials from 10 studies for meta-analysis. The quality assessment of included trials is summarized in Table 2. Notably, the comparisons between berberine (BBR) and metformin (MET), as well as between MET+BBR and MET alone, demonstrated intriguing results. The former comparison showed no significant differences in various parameters, while the latter revealed a combined treatment effect involving reductions in luteinizing hormone (LH), LH/follicle-stimulating hormone (FSH) ratio, and testosterone. Another significant focus was the comparison between combining cyproterone acetate (CPA) with BBR versus CPA alone, showing a more favorable impact on parameters like waist-hip ratio, insulin resistance, and lipid profiles in the CPA+BBR group. The discussion delved into BBR's effects on glycolipid metabolism, insulin resistance, and reproductive endocrine conditions. It also explored the potential benefits of combining BBR with Chinese herbs and highlighted BBR's relatively positive safety profile. In conclusion, the study suggested BBR's promise in treating PCOS-IR, but underscored the necessity for further well-designed trials to substantiate its effects and mechanisms in various treatment contexts.
Review Articles
Review articles summarise and critically evaluate the current state of research on a specific topic or field by synthesising multiple primary research studies.
Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2021 Apr 26 Frontiers in Pharmacology Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y, et al.
Berberine can improve obesity and hyperlipidemia by reducing triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL) and increasing high-density lipoprotein (HDL); reduce insulin resistance to improve type Ⅱ diabetes; and prevent diabetic encephalopathy.
Systematic Review Meta-Analysis Huang Lian Metabolic SyndromeCoptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology
2019 Jan 01 Pharmaceutical Biology Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, et al.
As an important herbal medicine in Chinese medicine, CR has the potential to treat various diseases. However, further research should be undertaken to investigate the clinical effects, toxic constituents, target organs and pharmacokinetics, and to establish criteria for quality control, for CR and its related medications. In addition, the active constituents, other than alkaloids, in both raw and processed products of CR should be investigated.
Review Article Huang LianThe Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review
2018 Nov 14 Evidence-Based Complementary and Alternative Medicine Meng-Fei Li, Xiao-Meng Zhou, Xue-Lian Li
Systematic Review Meta-Analysis Huang Bai Huang LianBerberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance.
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent
2016 Oct 07 Frontiers in Pharmacology Tan HL, Chan KG, Pusparajah P, Duangjai A, Saokaew S, Mehmood Khan T, et al.
In conclusion, results of recent studies appear to support for the usage of RC for treatment of CVDs and related conditions. RC appears to have tremendous potential as a cardioprotective agent given its ability to improve a large number of parameters associated with increased risk of CVDs including anti-atherosclerotic effect, lipid-lowering effect, anti-obesity effect and anti-hepatic steatosis effect. Aside from reducing incidence, it also reduces the damage caused by CVDs as it confers protection from myocardial I/R injury. However, knowledge regarding the underlying mechanisms of action of these compounds is still limited. More research investigating the exact mechanisms of RC's cardioprotective activities is needed.
Review Article Huang Lian Cardiovascular DiseaseClinical Trials
Clinical trials are research studies that involve people and are conducted to evaluate the safety and efficacy of new treatments or interventions, such as drugs, medical devices, or behavioural therapies.
Study Protocols
Published study protocols are detailed plans that outline the objectives, methodology, statistical analyses, and organisation of a research study that have been made publicly available for others to review and use as a reference.
Presentation Slides
Systematic Review
Berberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance.
Meng-Fei Li, Xiao-Meng Zhou, Xue-Lian Li
Executive Summary
Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Huang Lian" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.
Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Huang Lian" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.
Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Huang Lian" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.
A Systematic Review published in 2018 in the journal Evidence-Based Complementary and Alternative Medicine found that Berberine's potential similarity to metformin in addressing glycolipid metabolism and insulin sensitivity, and exploring promising combinations involving berberine, metformin, and cyproterone acetate for treating polycystic ovary syndrome with insulin resistance. The passage outlines the outcomes of a comprehensive study conducted in the context of treating polycystic ovary syndrome with insulin resistance (PCOS-IR). The study involved screening 225 potential studies, ultimately selecting 9 trials from 10 studies for meta-analysis. The quality assessment of included trials is summarized in Table 2. Notably, the comparisons between berberine (BBR) and metformin (MET), as well as between MET+BBR and MET alone, demonstrated intriguing results. The former comparison showed no significant differences in various parameters, while the latter revealed a combined treatment effect involving reductions in luteinizing hormone (LH), LH/follicle-stimulating hormone (FSH) ratio, and testosterone. Another significant focus was the comparison between combining cyproterone acetate (CPA) with BBR versus CPA alone, showing a more favorable impact on parameters like waist-hip ratio, insulin resistance, and lipid profiles in the CPA+BBR group. The discussion delved into BBR's effects on glycolipid metabolism, insulin resistance, and reproductive endocrine conditions. It also explored the potential benefits of combining BBR with Chinese herbs and highlighted BBR's relatively positive safety profile. In conclusion, the study suggested BBR's promise in treating PCOS-IR, but underscored the necessity for further well-designed trials to substantiate its effects and mechanisms in various treatment contexts.
Moderation Tools
Topic
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.